Advertisement

The Patient with Systemic Lupus Erythematosus

  • Michael Peck

Abstract

A 12-year-old black girl with no significant past medical history presented with the sudden onset of headache and lethargy. Her laboratory work showed thrombocytopenia (platelet count 8000/mm3). The hematologic differential diagnosis included idiopathic thrombocytopenic purpura and systemic lupus erythematosus. During evaluation the platelet count decreased to 5000/mm3. A CT scan showed a frontal intra-parenchymal hemorrhage. The patient developed hemiparesis, aphasia, and a dilated pupil. Dexamethasone 20mg was given and she was scheduled for emergency exploratory craniotomy. The presumptive diagnosis was hematoma caused by disruption of an arteriovenous malformation, most probably related to systemic lupus erythematosus.

Keywords

Systemic Lupus Erythematosus Lupus Nephritis Lupus Anticoagulant Black Girl Immune Complex Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Dubois E.L.: Lupus Erythematosus (monograph). Los Angeles, University of Southern California Press, 1978.Google Scholar
  2. 2.
    Eisele, J.H.: Connective tissue diseases, in Katz J., Benumof J., Kadis L.B. (eds): Anesthesia and Uncommon Diseases. Philadelphia: WB Saunders, 1990, p 654.Google Scholar
  3. 3.
    Schur PH.: Systemic lupus erythematosus, in Wyngaarden J., Smith L.H. Jr (eds): Cecil Textbook of Medicine. Philadelphia, WB Saunders, 1982, pp 1852–7.Google Scholar
  4. 4.
    Schaller J.: Lupus in childhood. Clin Rheum Dis 1982, 8: 219–25.PubMedGoogle Scholar
  5. 5.
    Hebra F., Kaposi M.: On Diseases of the Skin, Including the Exanthemata. Vol 4. Fagge H., Smith P, Tay W. (transi., eds): London: New Sydenham Society, 1874.Google Scholar
  6. 6.
    Klemperer P., Pollack A.D., Baehr G.: Pathology of disseminated lupus erythematosus. Arch Pathol 1941, 32: 569–631.Google Scholar
  7. 7.
    Tan E.M.: Autoantibodies to nuclear antigens: Their immunobiology and medicine. Adv Immunol 1982, 33: 167–72.PubMedCrossRefGoogle Scholar
  8. 8.
    Muller S.B.: Systemic lupus erythematosus, in Hurst J.W. (ed): Medicine for the Practicing Physician, 2nd edition. Boston: Butterworths, 1988, pp 228–32.Google Scholar
  9. 9.
    Abouleish E.: Obstetric anesthesia and systemic lupus erythematosus. Middle East J Anaesthesiol 1988, 9: 435–46.Google Scholar
  10. 10.
    Fine L.G., Barnett E.V., Danovitch G.M., et al.: Systemic lupus erythematosus in pregnancy. Ann Intern Med 1981, 94: 667–76.Google Scholar
  11. 11.
    Smith M.F.: Skin and connective tissue disorders, in Katz J., Steward D. (eds): Anesthesia and Uncommon Pediatric Diseases. Philadelphia: WB Saunders, 1987, pp 406–7.Google Scholar
  12. 12.
    Divertie M.B.: Lung involvement in the connective tissue disorders. Med Clin N Amer 1964, 48: 1015–30.PubMedGoogle Scholar
  13. 13.
    Balow J.E., Austin H.A. III, Muenzl R., et al.: Effective treatment of the evolution of renal abnormalities in lupus nephritis. N Engl J Med 1984, 311: 491–5.PubMedCrossRefGoogle Scholar
  14. 14.
    Feinglass E.J., Arnett F.C., Dersch C.A., et al.: Neuropsychiatric manifestations of systemic lupus erythematosus: Diagnosis, clinical spectrum and relationship to other features of the disease. Medicine 1976, 55: 323–39.PubMedCrossRefGoogle Scholar
  15. 15.
    Feinstein D.I., Rappaport S.I.: Acquired inhibitors of blood coagulation. Prog Hemost Thromb 1972, 1: 75–95.PubMedGoogle Scholar
  16. 16.
    Conley CL., Hartmann R.C.: A hemorrhagic disorder caused by circulating anticoagulants with disseminated lupus erythematosus. J Clin Invest 1952, 321: 621–22.Google Scholar
  17. 17.
    Schleider M.A., Nachman R.L., Jaffe E.A., et al.: A clinical study of lupus anticoagulant. Blood 1976, 48: 499–509.PubMedGoogle Scholar
  18. 18.
    Boxer M., Ellman L., Carvalo A.: The lupus anticoagulant. Arthritis Rheum 1976, 19: 1244–8.PubMedCrossRefGoogle Scholar
  19. 19.
    Mueh J.R., Herbst K.D., Rappaport S.I.: Thrombosis in patients with the lupus anticoagulant. Arch Intern Med 1980, 92: 156–9.Google Scholar
  20. 20.
    Elias M., Eldor A.: Thromboembolism in patients with the “lupus”-type circulating anticoagulant. Arch Intern Med 1984, 144: 510–15.PubMedCrossRefGoogle Scholar
  21. 21.
    Landi G., Calloni M.V., Sabadini M.G., et al.: Recurrent ischemic attacks in two young adults with lupus anticoagulant. Stroke 1983, 14: 377–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Englert HJ, Hawkes CH, Boey ML, et al.: Degos’ disease: association with anticardiolipin antibodies and the lupus anticoagulant. Br Med J 1984, 289: 576.CrossRefGoogle Scholar
  23. 23.
    Ke R.E., Gillman P.B., Kovacs A.D.: Cerebral ischemia in the presence of lupus anticoagulant. Arch Neurol 1984, 41: 521–3.CrossRefGoogle Scholar
  24. 24.
    Fisher M., McGehee W.: Cerebral infarct, TIA, and lupus inhibitor. Neurology 1986, 36: 1234–7.PubMedGoogle Scholar
  25. 25.
    Sourander L.B., Pulkkinen K.: Simultaneous occurrence of ankylosis of the cricoarytenoid joints with dyspnea and LE syndrome in rheumatoid arthritis. Acta Rheum Scand 1962, 8: 2557.CrossRefGoogle Scholar

Copyright information

© Birkhäuser Boston 1991

Authors and Affiliations

  • Michael Peck

There are no affiliations available

Personalised recommendations